Spinosad
Active ingredient: Spinosad
In short: Spinosad Topical Suspension is indicated for the topical treatment of head lice infestations in adult and pediatric patients 6 months of age and older. Adjunctive Measures for Head Lice Infestations Spinosad Topical Suspension should be used in the context of an overall lice management program: Wash
What is Spinosad used for?
Spinosad Topical Suspension is indicated for the topical treatment of head lice infestations in adult and pediatric patients 6 months of age and older.
Adjunctive Measures for Head Lice Infestations
Spinosad Topical Suspension should be used in the context of an overall lice management program:
Wash in hot water or dry-clean all recently worn clothing, hats, used bedding and towels.
Wash personal care items such as combs, brushes and hair clips in hot water.
A fine-tooth comb or special nit comb may be used to remove dead lice and nits.
Spinosad Topical Suspension is indicated for the topical treatment of scabies infestations in adult and pediatric patients 4 years of age and older.
Adjunctive Measures for Scabies Infestations
Wash in hot water or dry-clean any bedding, clothing and towels used by anyone having scabies.
Spinosad dosage
For topical use only. Spinosad Topical Suspension is not for oral, ophthalmic, or intravaginal use.
Avoid contact with eyes. If Spinosad Topical Suspension gets in or near the eyes, rinse thoroughly with water.
Shake bottle well.
Apply a sufficient amount of Spinosad Topical Suspension to cover dry scalp, then apply to dry hair. Depending on hair length, apply up to 120 mL (one bottle) to adequately cover scalp and hair.
Leave on for 10 minutes, then thoroughly rinse off with warm water.
Wash hands after use.
If live lice are seen 7 days after the first treatment, a second treatment should be applied.
Apply Spinosad Topical Suspension on pediatric patient only under direct supervision of an adult
.
Shake bottle well.
Apply a sufficient amount of Spinosad Topical Suspension to skin to completely cover the body from the neck to the toes (including the soles of the feet).
For patients with balding scalp, also apply product to the scalp, hairline, temples, and forehead.
Allow to absorb into the skin and dry for 10 minutes before getting dressed.
Leave on the skin for at least 6 hours before showering or bathing.
Apply Spinosad Topical Suspension on pediatric patient only under direct supervision of an adult
.
How to take Spinosad — instructions & advice from the label
Advise patients to read the FDA-approved patient labeling (Patient Information)
Important Administration Instructions
Instruct the patient to:
Shake bottle well immediately prior to application.
Do not swallow.
Avoid contact with eyes. If Spinosad Topical Suspension gets in or near the eyes, rinse thoroughly with water.
Apply Spinosad Topical Suspension on pediatric patient only under direct supervision of an adult.
If skin/scalp irritation occurs after use, contact your physician
.
Head Lice Infestation Treatment
Apply Spinosad Topical Suspension only on dry scalp and dry scalp hair.
Repeat treatment only if live lice are seen seven (7) days after first treatment.
Wash hands after applying Spinosad Topical Suspension.
Scabies Infestation Treatment
Apply Spinosad Topical Suspension to completely cover the body from the neck to the toes (including the soles of the feet).
For patients with balding scalp,also apply product to the scalp, hairline, temples, and forehead.
Allow it to absorb in the skin and dry for 10 minutes before getting dressed.
Leave on the skin for at least 6 hours before showering or bathing. …
Warnings & precautions
Do not take this medicine if: None.
Spinosad Topical Suspension contains benzyl alcohol and is not approved for use in neonates and infants below the age of 6 months. Systemic exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants when administered intravenously
.
Spinosad side effects
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in clinical practice.
Head Lice Infestations
Spinosad Topical Suspension was studied in two randomized, active-controlled trials (N=552) in subjects with head lice; Table 1 presents selected adverse events, regardless of relationship to Spinosad Topical Suspension, that occurred in at least 1% of subjects.
Signs | Spinosad (N=552) | Permethrin 1% (N=457)
Application site erythema | 17 (3%) | 31(7%)
Ocular erythema | 12 (2%) | 15 (3%)
Application site irritation | 5 (1%) | 7 (2%)
Other less common reactions (less than 1% but more than 0.1%) were application site dryness, application site exfoliation, alopecia, and dry skin.
Scabies Infestations
Spinosad Topical Suspension was studied in three randomized, double-blind, vehicle-controlled trials (Trial 1, Trial 2, and Trial 3) in 592 subjects with scabies infestation, of which 165 were ages 4-17 and 427 were adults. Subjects received a single application of Spinosad Topical Suspension to the skin from the neck to the soles of the feet, which was washed off after a minimum of 6 hours. Table 2 presents adverse reactions related to Spinosad Topical Suspension treatment that occurred in at least 1% of subjects. …
About this medicine
Spinosad Topical Suspension is a slightly opaque, light orange-colored, viscous topical suspension.
Spinosad Topical Suspension is a pediculicide and scabicide. Spinosad, the active ingredient, is derived from the fermentation of a soil actinomycete bacterium,
Saccharopolyspora spinosa.
Spinosad is a mixture of spinosyn A and spinosyn D in a ratio of approximately 5 to 1 (spinosyn A to spinosyn D).
Spinosyn A:The chemical name is: 1
H-as-Indaceno[3,2-d]oxacyclododecin-7,a5-dione, 2-[(6-deoxy-2,3,4-tri-O- methyl-alpha-L-mannopyranosyl)oxy]-13-[[2R,5S,6R)-5-(dimethylamino) tetrahydro-6-methyl-2
H-pyran-2- yl]oxy]-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-14-methyl-, (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-
Spinosyn D:The chemical name is: 1
H-as-Indaceno[3,2-d]oxacyclododecin-7,15-dione, 2-[(6-deoxy-2,3,4-tri-O- methyl-alpha-L-mannopyranosyl)oxy]-13-[[2R,5S,6R)-5-(dimethylamino) tetrahydro-6-methyl-2
H-pyran-2- yl]oxy]-9-ethyl-2,3,3a,5a,5b,6,9,10,11,12,13,14,16a,16b-tetradecahydro-4,14-dimethyl-, (2S,3aSR,5aS,5bS,9S,13S,14R,16aS,16bS)-
Spinosyn A (C
41H
65NO
10)
MW …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 16a95039-0df7-45d5-8b51-bbc81443fea3. Read the full official label on DailyMed.